According to The Times of India, United Breweries (UBL) and Max Healthcare have been identified as top buy recommendations for July 29, 2026. United Breweries is recommended as a buy with a price range of ₹1,430-₹1,410 and a target of ₹1,565, while Max Healthcare is suggested at ₹1,120-₹1,110 with a target of ₹1,200. As reported by The Times of India, these recommendations come from Mehul Kothari, DVP - Technical Research at Anand Rathi Shares.
According to the technical analysis reported by The Times of India, United Breweries is showing signs of a potential reversal after correcting sharply from its recent highs. The stock has been under selling pressure since scaling above ₹2,200 in April 2025, but recent developments suggest a turnaround is emerging. The stock bounced back after testing its 50-day moving average on daily charts, which indicates that bulls are trying to make a comeback. Short-term traders with a high-risk profile can consider buying the stock for a possible bounce towards ₹1,500 levels, as technical indicators and price action suggest weakening selling pressure and returning buyers.
As reported by The Times of India, Max Healthcare has resumed its upward momentum after taking support near the 50-day EMA, indicating that the broader bullish trend remains intact. The stock has witnessed a strong rebound from lower levels, while the RSI around 57 reflects improving strength without entering the overbought zone. Although the MACD is witnessing a mild loss in momentum, it remains in positive territory, suggesting the primary trend is still favourable.
According to the recommendations from Anand Rathi Shares, traders may consider entering long positions in the ₹1,430-₹1,410 zone for United Breweries with a target of ₹1,565, while Max Healthcare can be entered in the ₹1,120-₹1,110 zone with a target of ₹1,200. As reported by The Times of India, Adani Enterprises has been identified as a sell call for the same trading session. United Breweries closed at ₹1,438 on July 29, 2026, marking a significant decline from its high of ₹1,999 on July 30, 2025, but the recent bounce back after testing the 50-day moving average suggests potential recovery momentum.
